Abstract：Objective To investigate the clinical effect of Huoxue Mingmu Decoction Invigorate in the treatment of nonproliferative diabetic retinopathy (NDPR).Methods A total of 80 patients with NDPR who admitted to Jingmen Hospital of Traditional Chinese Medicine in Hubei Province from June 2017 to July 2018 were selected as the research objects and divided into the control group and the observation group by random draw method,with 40 cases in each group.The control group was treated with Calcium Dobesilate Capsules,the observation group was treated with Huoxue Mingmu Decoction Invigorate.Patients in both groups were treated for 1 month.The total effective rate,the indicators of fundus lesions and the incidence of adverse reactions before and after treatment were compared between the two groups.Results The total effective rate of the observation group (87.5%) was higher than that of the control group(62.5%),and the difference was statistically significant (P＜0.05).After treatment,the volume of fundus microangioma,hemorrhagic plaque and macular thickness in the observation group were lower than those in the control group,and the differences were statistically significant (P＜0.05).There were no adverse reactions in both groups during and after treatment.Conclusion The clinical efficacy of Huoxue Mingmu Decoction Invigorate in the treatment of NDPR is better than Calcium Dobesilate Capsules.
Yang B，Li M，Chen B，et al.Racial differences of endothelin function and plasma endothelin-1 level in preclinical Tibetan and Han male population[J].Aadolu Kardiyol Dreg，2013，13（2）：188-189.
京公网安备 11010502046607号